| 000 | 01902 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250515034655.0 | ||
| 264 | 0 | _c20070125 | |
| 008 | 200701s 0 0 eng d | ||
| 022 | _a1365-7852 | ||
| 024 | 7 |
_a10.1038/sj.pcan.4500903 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAnscher, M S | |
| 245 | 0 | 0 |
_aTiming and patterns of recurrences and deaths from prostate cancer following adjuvant pelvic radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate. _h[electronic resource] |
| 260 |
_bProstate cancer and prostatic diseases _c2006 |
||
| 300 |
_a254-60 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xmortality |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aPelvis _xradiation effects |
| 650 | 0 | 4 |
_aProstatectomy _xmethods |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xmortality |
| 650 | 0 | 4 | _aRadiation Dosage |
| 650 | 0 | 4 | _aRadiotherapy, Adjuvant |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Failure |
| 700 | 1 | _aClough, R | |
| 700 | 1 | _aRobertson, C N | |
| 700 | 1 | _aProsnitz, L R | |
| 700 | 1 | _aDahm, P | |
| 700 | 1 | _aWalther, P | |
| 700 | 1 | _aDonatucci, C F | |
| 700 | 1 | _aAlbala, D M | |
| 700 | 1 | _aFebbo, P | |
| 700 | 1 | _aGeorge, D J | |
| 700 | 1 | _aSun, L | |
| 700 | 1 | _aMoul, J W | |
| 773 | 0 |
_tProstate cancer and prostatic diseases _gvol. 9 _gno. 3 _gp. 254-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.pcan.4500903 _zAvailable from publisher's website |
| 999 |
_c16469579 _d16469579 |
||